nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2D6—Parkinson's disease	0.329	0.583	CbGaD
Loperamide—ABCB1—Parkinson's disease	0.235	0.417	CbGaD
Loperamide—POMC—adrenal medulla—Parkinson's disease	0.0201	0.0994	CbGeAlD
Loperamide—POMC—locus ceruleus—Parkinson's disease	0.0169	0.0837	CbGeAlD
Loperamide—POMC—sympathetic nervous system—Parkinson's disease	0.0133	0.0661	CbGeAlD
Loperamide—CACNA1A—cerebellar cortex—Parkinson's disease	0.0131	0.0651	CbGeAlD
Loperamide—POMC—autonomic nervous system—Parkinson's disease	0.00897	0.0445	CbGeAlD
Loperamide—POMC—telencephalic ventricle—Parkinson's disease	0.00801	0.0397	CbGeAlD
Loperamide—CALM1—superior cervical ganglion—Parkinson's disease	0.00665	0.033	CbGeAlD
Loperamide—POMC—peripheral nervous system—Parkinson's disease	0.00647	0.0321	CbGeAlD
Loperamide—CALM2—adrenal medulla—Parkinson's disease	0.00548	0.0272	CbGeAlD
Loperamide—CALM1—adrenal medulla—Parkinson's disease	0.00545	0.027	CbGeAlD
Loperamide—POMC—nerve—Parkinson's disease	0.00505	0.025	CbGeAlD
Loperamide—CACNA1A—nerve—Parkinson's disease	0.00482	0.0239	CbGeAlD
Loperamide—POMC—hindbrain—Parkinson's disease	0.00378	0.0187	CbGeAlD
Loperamide—CALM1—sympathetic nervous system—Parkinson's disease	0.00363	0.018	CbGeAlD
Loperamide—CACNA1A—hindbrain—Parkinson's disease	0.00361	0.0179	CbGeAlD
Loperamide—OPRM1—telencephalic ventricle—Parkinson's disease	0.00301	0.0149	CbGeAlD
Loperamide—CALM2—pons—Parkinson's disease	0.00266	0.0132	CbGeAlD
Loperamide—CALM1—pons—Parkinson's disease	0.00264	0.0131	CbGeAlD
Loperamide—CALM1—autonomic nervous system—Parkinson's disease	0.00244	0.0121	CbGeAlD
Loperamide—POMC—brainstem—Parkinson's disease	0.00217	0.0107	CbGeAlD
Loperamide—POMC—forebrain—Parkinson's disease	0.00209	0.0104	CbGeAlD
Loperamide—CACNA1A—brainstem—Parkinson's disease	0.00207	0.0102	CbGeAlD
Loperamide—CACNA1A—forebrain—Parkinson's disease	0.002	0.00989	CbGeAlD
Loperamide—OPRM1—nerve—Parkinson's disease	0.0019	0.00941	CbGeAlD
Loperamide—CALM2—peripheral nervous system—Parkinson's disease	0.00177	0.00876	CbGeAlD
Loperamide—POMC—cardiovascular system—Parkinson's disease	0.00177	0.00876	CbGeAlD
Loperamide—CALM1—peripheral nervous system—Parkinson's disease	0.00176	0.00872	CbGeAlD
Loperamide—POMC—medulla oblongata—Parkinson's disease	0.00151	0.00749	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—Parkinson's disease	0.00144	0.00715	CbGeAlD
Loperamide—POMC—midbrain—Parkinson's disease	0.00138	0.00684	CbGeAlD
Loperamide—CALM2—nerve—Parkinson's disease	0.00138	0.00683	CbGeAlD
Loperamide—CALM1—nerve—Parkinson's disease	0.00137	0.0068	CbGeAlD
Loperamide—POMC—spinal cord—Parkinson's disease	0.00135	0.00668	CbGeAlD
Loperamide—POMC—head—Parkinson's disease	0.0012	0.00593	CbGeAlD
Loperamide—OPRD1—forebrain—Parkinson's disease	0.00115	0.00572	CbGeAlD
Loperamide—CACNA1A—head—Parkinson's disease	0.00114	0.00566	CbGeAlD
Loperamide—POMC—nervous system—Parkinson's disease	0.00113	0.00562	CbGeAlD
Loperamide—OPRK1—forebrain—Parkinson's disease	0.00111	0.00548	CbGeAlD
Loperamide—POMC—central nervous system—Parkinson's disease	0.00109	0.00542	CbGeAlD
Loperamide—CACNA1A—nervous system—Parkinson's disease	0.00108	0.00537	CbGeAlD
Loperamide—POMC—cerebellum—Parkinson's disease	0.00107	0.00529	CbGeAlD
Loperamide—CACNA1A—central nervous system—Parkinson's disease	0.00104	0.00517	CbGeAlD
Loperamide—CALM2—hindbrain—Parkinson's disease	0.00103	0.00512	CbGeAlD
Loperamide—CALM1—hindbrain—Parkinson's disease	0.00103	0.00509	CbGeAlD
Loperamide—CACNA1A—cerebellum—Parkinson's disease	0.00102	0.00505	CbGeAlD
Loperamide—POMC—brain—Parkinson's disease	0.000867	0.0043	CbGeAlD
Loperamide—Haloperidol—GRIN2B—Parkinson's disease	0.000837	0.146	CrCbGaD
Loperamide—CACNA1A—brain—Parkinson's disease	0.000828	0.0041	CbGeAlD
Loperamide—OPRM1—brainstem—Parkinson's disease	0.000815	0.00404	CbGeAlD
Loperamide—OPRM1—forebrain—Parkinson's disease	0.000787	0.0039	CbGeAlD
Loperamide—OPRD1—head—Parkinson's disease	0.000661	0.00327	CbGeAlD
Loperamide—CALM2—embryo—Parkinson's disease	0.000646	0.0032	CbGeAlD
Loperamide—CALM1—embryo—Parkinson's disease	0.000643	0.00318	CbGeAlD
Loperamide—OPRK1—head—Parkinson's disease	0.000633	0.00314	CbGeAlD
Loperamide—OPRD1—nervous system—Parkinson's disease	0.000626	0.0031	CbGeAlD
Loperamide—OPRD1—central nervous system—Parkinson's disease	0.000603	0.00299	CbGeAlD
Loperamide—OPRK1—nervous system—Parkinson's disease	0.0006	0.00298	CbGeAlD
Loperamide—CALM2—brainstem—Parkinson's disease	0.000592	0.00293	CbGeAlD
Loperamide—CALM1—brainstem—Parkinson's disease	0.000589	0.00292	CbGeAlD
Loperamide—OPRK1—central nervous system—Parkinson's disease	0.000578	0.00286	CbGeAlD
Loperamide—CALM2—forebrain—Parkinson's disease	0.000571	0.00283	CbGeAlD
Loperamide—CYP2D6—hindbrain—Parkinson's disease	0.00057	0.00283	CbGeAlD
Loperamide—CALM1—forebrain—Parkinson's disease	0.000568	0.00282	CbGeAlD
Loperamide—OPRK1—cerebellum—Parkinson's disease	0.000565	0.0028	CbGeAlD
Loperamide—CALM3—medulla oblongata—Parkinson's disease	0.000525	0.0026	CbGeAlD
Loperamide—OPRM1—midbrain—Parkinson's disease	0.00052	0.00257	CbGeAlD
Loperamide—OPRM1—spinal cord—Parkinson's disease	0.000507	0.00251	CbGeAlD
Loperamide—CALM2—cardiovascular system—Parkinson's disease	0.000483	0.00239	CbGeAlD
Loperamide—CALM1—cardiovascular system—Parkinson's disease	0.000481	0.00238	CbGeAlD
Loperamide—CALM3—midbrain—Parkinson's disease	0.00048	0.00238	CbGeAlD
Loperamide—OPRD1—brain—Parkinson's disease	0.000479	0.00237	CbGeAlD
Loperamide—CALM3—spinal cord—Parkinson's disease	0.000468	0.00232	CbGeAlD
Loperamide—OPRK1—brain—Parkinson's disease	0.000459	0.00227	CbGeAlD
Loperamide—OPRM1—head—Parkinson's disease	0.00045	0.00223	CbGeAlD
Loperamide—Clemastine—CYP2D6—Parkinson's disease	0.000431	0.0749	CrCbGaD
Loperamide—OPRM1—nervous system—Parkinson's disease	0.000427	0.00212	CbGeAlD
Loperamide—Haloperidol—DRD3—Parkinson's disease	0.000425	0.0739	CrCbGaD
Loperamide—Haloperidol—DRD1—Parkinson's disease	0.000417	0.0725	CrCbGaD
Loperamide—CALM2—medulla oblongata—Parkinson's disease	0.000413	0.00204	CbGeAlD
Loperamide—OPRM1—central nervous system—Parkinson's disease	0.000411	0.00204	CbGeAlD
Loperamide—CALM1—medulla oblongata—Parkinson's disease	0.000411	0.00204	CbGeAlD
Loperamide—CALM2—midbrain—Parkinson's disease	0.000377	0.00187	CbGeAlD
Loperamide—CALM1—midbrain—Parkinson's disease	0.000375	0.00186	CbGeAlD
Loperamide—CALM3—cerebellum—Parkinson's disease	0.000371	0.00184	CbGeAlD
Loperamide—CALM2—spinal cord—Parkinson's disease	0.000368	0.00182	CbGeAlD
Loperamide—CALM1—spinal cord—Parkinson's disease	0.000366	0.00181	CbGeAlD
Loperamide—CYP2B6—cardiovascular system—Parkinson's disease	0.000359	0.00178	CbGeAlD
Loperamide—CALM2—head—Parkinson's disease	0.000327	0.00162	CbGeAlD
Loperamide—CYP2D6—brainstem—Parkinson's disease	0.000327	0.00162	CbGeAlD
Loperamide—OPRM1—brain—Parkinson's disease	0.000326	0.00162	CbGeAlD
Loperamide—CALM1—head—Parkinson's disease	0.000325	0.00161	CbGeAlD
Loperamide—CYP2D6—forebrain—Parkinson's disease	0.000315	0.00156	CbGeAlD
Loperamide—Clotrimazole—CYP2E1—Parkinson's disease	0.000315	0.0547	CrCbGaD
Loperamide—CALM2—nervous system—Parkinson's disease	0.00031	0.00154	CbGeAlD
Loperamide—CALM1—nervous system—Parkinson's disease	0.000309	0.00153	CbGeAlD
Loperamide—Darifenacin—CYP2D6—Parkinson's disease	0.000307	0.0534	CrCbGaD
Loperamide—CALM3—brain—Parkinson's disease	0.000302	0.0015	CbGeAlD
Loperamide—Fexofenadine—CYP2D6—Parkinson's disease	0.000299	0.0519	CrCbGaD
Loperamide—CALM2—central nervous system—Parkinson's disease	0.000298	0.00148	CbGeAlD
Loperamide—CALM1—central nervous system—Parkinson's disease	0.000297	0.00147	CbGeAlD
Loperamide—Haloperidol—DRD2—Parkinson's disease	0.000294	0.0511	CrCbGaD
Loperamide—CALM2—cerebellum—Parkinson's disease	0.000292	0.00145	CbGeAlD
Loperamide—CALM1—cerebellum—Parkinson's disease	0.00029	0.00144	CbGeAlD
Loperamide—ABCB1—embryo—Parkinson's disease	0.000257	0.00127	CbGeAlD
Loperamide—Toremifene—ABCB1—Parkinson's disease	0.000244	0.0424	CrCbGaD
Loperamide—CYP2B6—head—Parkinson's disease	0.000243	0.0012	CbGeAlD
Loperamide—CALM2—brain—Parkinson's disease	0.000237	0.00117	CbGeAlD
Loperamide—CALM1—brain—Parkinson's disease	0.000236	0.00117	CbGeAlD
Loperamide—Clotrimazole—CYP2D6—Parkinson's disease	0.000231	0.0401	CrCbGaD
Loperamide—CYP2B6—nervous system—Parkinson's disease	0.00023	0.00114	CbGeAlD
Loperamide—Haloperidol—HTR2A—Parkinson's disease	0.000227	0.0395	CrCbGaD
Loperamide—ABCB1—forebrain—Parkinson's disease	0.000227	0.00112	CbGeAlD
Loperamide—CYP2B6—central nervous system—Parkinson's disease	0.000222	0.0011	CbGeAlD
Loperamide—Fexofenadine—ABCB1—Parkinson's disease	0.000213	0.0371	CrCbGaD
Loperamide—Haloperidol—CYP2D6—Parkinson's disease	0.000208	0.0361	CrCbGaD
Loperamide—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.0002	0.0347	CrCbGaD
Loperamide—CYP2C8—brain—Parkinson's disease	0.000196	0.000973	CbGeAlD
Loperamide—ABCB1—cardiovascular system—Parkinson's disease	0.000192	0.000951	CbGeAlD
Loperamide—Tamoxifen—CYP2E1—Parkinson's disease	0.000186	0.0323	CrCbGaD
Loperamide—CYP2D6—head—Parkinson's disease	0.000181	0.000895	CbGeAlD
Loperamide—CYP2B6—brain—Parkinson's disease	0.000176	0.000873	CbGeAlD
Loperamide—CYP3A4—nervous system—Parkinson's disease	0.000174	0.000862	CbGeAlD
Loperamide—CYP2D6—nervous system—Parkinson's disease	0.000171	0.000849	CbGeAlD
Loperamide—CYP3A4—central nervous system—Parkinson's disease	0.000168	0.00083	CbGeAlD
Loperamide—Clotrimazole—ABCB1—Parkinson's disease	0.000165	0.0287	CrCbGaD
Loperamide—CYP2D6—central nervous system—Parkinson's disease	0.000165	0.000817	CbGeAlD
Loperamide—ABCB1—medulla oblongata—Parkinson's disease	0.000164	0.000812	CbGeAlD
Loperamide—CYP2D6—cerebellum—Parkinson's disease	0.000161	0.000799	CbGeAlD
Loperamide—ABCB1—midbrain—Parkinson's disease	0.00015	0.000743	CbGeAlD
Loperamide—Haloperidol—ABCB1—Parkinson's disease	0.000148	0.0258	CrCbGaD
Loperamide—ABCB1—spinal cord—Parkinson's disease	0.000146	0.000724	CbGeAlD
Loperamide—Fentanyl—ABCB1—Parkinson's disease	0.000141	0.0245	CrCbGaD
Loperamide—Tamoxifen—CYP2D6—Parkinson's disease	0.000137	0.0237	CrCbGaD
Loperamide—Methadone—CYP2D6—Parkinson's disease	0.000135	0.0235	CrCbGaD
Loperamide—CYP2D6—brain—Parkinson's disease	0.000131	0.000649	CbGeAlD
Loperamide—ABCB1—head—Parkinson's disease	0.00013	0.000644	CbGeAlD
Loperamide—ABCB1—nervous system—Parkinson's disease	0.000123	0.00061	CbGeAlD
Loperamide—ABCB1—central nervous system—Parkinson's disease	0.000119	0.000588	CbGeAlD
Loperamide—ABCB1—cerebellum—Parkinson's disease	0.000116	0.000574	CbGeAlD
Loperamide—Tamoxifen—ABCB1—Parkinson's disease	9.75e-05	0.0169	CrCbGaD
Loperamide—Methadone—ABCB1—Parkinson's disease	9.67e-05	0.0168	CrCbGaD
Loperamide—ABCB1—brain—Parkinson's disease	9.41e-05	0.000467	CbGeAlD
Loperamide—CALM1—Metabolism—CYP2D6—Parkinson's disease	1.28e-05	5.59e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADORA2A—Parkinson's disease	1.27e-05	5.58e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.27e-05	5.58e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.27e-05	5.55e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EDN1—Parkinson's disease	1.27e-05	5.55e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EDN1—Parkinson's disease	1.27e-05	5.55e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	1.26e-05	5.54e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—ABL1—Parkinson's disease	1.26e-05	5.51e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CTGF—Parkinson's disease	1.25e-05	5.49e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CTGF—Parkinson's disease	1.25e-05	5.49e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	1.25e-05	5.48e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	1.24e-05	5.43e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NQO1—Parkinson's disease	1.22e-05	5.37e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—ABL1—Parkinson's disease	1.22e-05	5.33e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—ABL1—Parkinson's disease	1.22e-05	5.33e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—INSR—Parkinson's disease	1.21e-05	5.32e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—TH—Parkinson's disease	1.21e-05	5.29e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CYP2E1—Parkinson's disease	1.21e-05	5.29e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—APOE—Parkinson's disease	1.2e-05	5.27e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NQO1—Parkinson's disease	1.19e-05	5.23e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HGF—Parkinson's disease	1.18e-05	5.18e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—TH—Parkinson's disease	1.17e-05	5.15e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—INSR—Parkinson's disease	1.17e-05	5.15e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—INSR—Parkinson's disease	1.17e-05	5.15e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—INS—Parkinson's disease	1.17e-05	5.13e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CYP2E1—Parkinson's disease	1.17e-05	5.11e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CYP2E1—Parkinson's disease	1.17e-05	5.11e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CYCS—Parkinson's disease	1.16e-05	5.08e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NQO1—Parkinson's disease	1.15e-05	5.06e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NQO1—Parkinson's disease	1.15e-05	5.06e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NGF—Parkinson's disease	1.15e-05	5.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGB—Parkinson's disease	1.15e-05	5.03e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	1.15e-05	5.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HTR2A—Parkinson's disease	1.14e-05	5.02e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HGF—Parkinson's disease	1.14e-05	5.01e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HGF—Parkinson's disease	1.14e-05	5.01e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR1A—Parkinson's disease	1.14e-05	5e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—TH—Parkinson's disease	1.14e-05	4.98e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—TH—Parkinson's disease	1.14e-05	4.98e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CYCS—Parkinson's disease	1.13e-05	4.95e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CTGF—Parkinson's disease	1.13e-05	4.94e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TAC1—Parkinson's disease	1.12e-05	4.93e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGB—Parkinson's disease	1.11e-05	4.87e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGB—Parkinson's disease	1.11e-05	4.87e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HTR2A—Parkinson's disease	1.11e-05	4.86e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.11e-05	4.86e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR1A—Parkinson's disease	1.1e-05	4.84e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR1A—Parkinson's disease	1.1e-05	4.84e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD1—Parkinson's disease	1.1e-05	4.83e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—IL6—Parkinson's disease	1.09e-05	4.79e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.09e-05	4.79e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CYCS—Parkinson's disease	1.09e-05	4.79e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CYCS—Parkinson's disease	1.09e-05	4.79e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TAC1—Parkinson's disease	1.09e-05	4.77e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TAC1—Parkinson's disease	1.09e-05	4.77e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD3—Parkinson's disease	1.07e-05	4.68e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD1—Parkinson's disease	1.07e-05	4.68e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD1—Parkinson's disease	1.07e-05	4.68e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—IL6—Parkinson's disease	1.06e-05	4.63e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—IL6—Parkinson's disease	1.06e-05	4.63e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	1.05e-05	4.6e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NQO1—Parkinson's disease	1.04e-05	4.55e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD3—Parkinson's disease	1.03e-05	4.53e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD3—Parkinson's disease	1.03e-05	4.53e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—COMT—Parkinson's disease	1.03e-05	4.5e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—INS—Parkinson's disease	1.03e-05	4.5e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TH—Parkinson's disease	1.02e-05	4.48e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTP1—Parkinson's disease	1.02e-05	4.48e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MAOA—Parkinson's disease	1.02e-05	4.47e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOE—Parkinson's disease	1.02e-05	4.45e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—HMOX1—Parkinson's disease	1.01e-05	4.42e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP2D6—Parkinson's disease	9.99e-06	4.38e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—COMT—Parkinson's disease	9.99e-06	4.38e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADRBK1—Parkinson's disease	9.97e-06	4.37e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTP1—Parkinson's disease	9.94e-06	4.36e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MAOA—Parkinson's disease	9.92e-06	4.35e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DDC—Parkinson's disease	9.84e-06	4.31e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CYCS—Parkinson's disease	9.81e-06	4.3e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CTGF—Parkinson's disease	9.81e-06	4.3e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—HMOX1—Parkinson's disease	9.81e-06	4.3e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MAPK8—Parkinson's disease	9.76e-06	4.28e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ABCB1—Parkinson's disease	9.67e-06	4.24e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—COMT—Parkinson's disease	9.66e-06	4.24e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—COMT—Parkinson's disease	9.66e-06	4.24e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD2—Parkinson's disease	9.65e-06	4.23e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR7—Parkinson's disease	9.65e-06	4.23e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADRBK1—Parkinson's disease	9.64e-06	4.23e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADRBK1—Parkinson's disease	9.64e-06	4.23e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—MTHFR—Parkinson's disease	9.64e-06	4.23e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTP1—Parkinson's disease	9.62e-06	4.22e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTP1—Parkinson's disease	9.62e-06	4.22e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MAOA—Parkinson's disease	9.6e-06	4.21e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MAOA—Parkinson's disease	9.6e-06	4.21e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—HMOX1—Parkinson's disease	9.49e-06	4.16e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—HMOX1—Parkinson's disease	9.49e-06	4.16e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MAPK8—Parkinson's disease	9.44e-06	4.14e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MAPK8—Parkinson's disease	9.44e-06	4.14e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ABCB1—Parkinson's disease	9.41e-06	4.13e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTM1—Parkinson's disease	9.39e-06	4.12e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR7—Parkinson's disease	9.34e-06	4.1e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR7—Parkinson's disease	9.34e-06	4.1e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD2—Parkinson's disease	9.34e-06	4.1e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD2—Parkinson's disease	9.34e-06	4.1e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—MTHFR—Parkinson's disease	9.33e-06	4.09e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—MTHFR—Parkinson's disease	9.33e-06	4.09e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.29e-06	4.07e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CTGF—Parkinson's disease	9.24e-06	4.05e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP2E1—Parkinson's disease	9.14e-06	4.01e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTM1—Parkinson's disease	9.14e-06	4.01e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ABCB1—Parkinson's disease	9.1e-06	3.99e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ABCB1—Parkinson's disease	9.1e-06	3.99e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NQO1—Parkinson's disease	9.03e-06	3.96e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GPX1—Parkinson's disease	8.99e-06	3.94e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—APOE—Parkinson's disease	8.98e-06	3.94e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TH—Parkinson's disease	8.9e-06	3.9e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTM1—Parkinson's disease	8.84e-06	3.88e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTM1—Parkinson's disease	8.84e-06	3.88e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GPX1—Parkinson's disease	8.75e-06	3.84e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	8.72e-06	3.82e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—COMT—Parkinson's disease	8.69e-06	3.81e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—APOE—Parkinson's disease	8.68e-06	3.81e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—APOE—Parkinson's disease	8.68e-06	3.81e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—INS—Parkinson's disease	8.68e-06	3.8e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	8.66e-06	3.8e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTP1—Parkinson's disease	8.65e-06	3.79e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MAOA—Parkinson's disease	8.63e-06	3.78e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.61e-06	3.78e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYCS—Parkinson's disease	8.55e-06	3.75e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—HMOX1—Parkinson's disease	8.53e-06	3.74e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.51e-06	3.73e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GPX1—Parkinson's disease	8.46e-06	3.71e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GPX1—Parkinson's disease	8.46e-06	3.71e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TH—Parkinson's disease	8.39e-06	3.68e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.37e-06	3.67e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MTHFR—Parkinson's disease	8.3e-06	3.64e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.28e-06	3.63e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ABCB1—Parkinson's disease	8.19e-06	3.59e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF2—Parkinson's disease	8.09e-06	3.55e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MTHFR—Parkinson's disease	8.07e-06	3.54e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CYCS—Parkinson's disease	8.06e-06	3.53e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	8.01e-06	3.51e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTM1—Parkinson's disease	7.95e-06	3.49e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF2—Parkinson's disease	7.83e-06	3.43e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF2—Parkinson's disease	7.83e-06	3.43e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1R—Parkinson's disease	7.82e-06	3.43e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MTHFR—Parkinson's disease	7.81e-06	3.43e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MTHFR—Parkinson's disease	7.81e-06	3.43e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EDN1—Parkinson's disease	7.73e-06	3.39e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—Parkinson's disease	7.72e-06	3.39e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—INS—Parkinson's disease	7.67e-06	3.36e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	7.64e-06	3.35e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GPX1—Parkinson's disease	7.61e-06	3.34e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	7.59e-06	3.33e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—COMT—Parkinson's disease	7.57e-06	3.32e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1R—Parkinson's disease	7.57e-06	3.32e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1R—Parkinson's disease	7.57e-06	3.32e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTP1—Parkinson's disease	7.54e-06	3.3e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MAOA—Parkinson's disease	7.52e-06	3.3e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—Parkinson's disease	7.52e-06	3.3e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EDN1—Parkinson's disease	7.48e-06	3.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EDN1—Parkinson's disease	7.48e-06	3.28e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—HMOX1—Parkinson's disease	7.43e-06	3.26e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—INS—Parkinson's disease	7.42e-06	3.25e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—INS—Parkinson's disease	7.42e-06	3.25e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—Parkinson's disease	7.27e-06	3.19e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—Parkinson's disease	7.27e-06	3.19e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—COMT—Parkinson's disease	7.13e-06	3.13e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NGF—Parkinson's disease	7.1e-06	3.11e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.1e-06	3.11e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.08e-06	3.11e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—Parkinson's disease	7.02e-06	3.08e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	7.02e-06	3.08e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7e-06	3.07e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.92e-06	3.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NGF—Parkinson's disease	6.87e-06	3.01e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NGF—Parkinson's disease	6.87e-06	3.01e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—Parkinson's disease	6.76e-06	2.97e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.72e-06	2.95e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GPX1—Parkinson's disease	6.63e-06	2.91e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—INS—Parkinson's disease	6.6e-06	2.89e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—Parkinson's disease	6.54e-06	2.87e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—Parkinson's disease	6.54e-06	2.87e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—Parkinson's disease	6.54e-06	2.87e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.53e-06	2.86e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	6.46e-06	2.83e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—INS—Parkinson's disease	6.42e-06	2.82e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	6.42e-06	2.81e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—Parkinson's disease	6.29e-06	2.76e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.25e-06	2.74e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—Parkinson's disease	6.23e-06	2.73e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—INS—Parkinson's disease	6.21e-06	2.72e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—INS—Parkinson's disease	6.21e-06	2.72e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—Parkinson's disease	6.2e-06	2.72e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.15e-06	2.7e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—Parkinson's disease	6.12e-06	2.68e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—Parkinson's disease	6.08e-06	2.67e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—Parkinson's disease	6.08e-06	2.67e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.04e-06	2.65e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—Parkinson's disease	6.03e-06	2.64e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—Parkinson's disease	6.03e-06	2.64e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—Parkinson's disease	6e-06	2.63e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—Parkinson's disease	6e-06	2.63e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	5.94e-06	2.6e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.77e-06	2.53e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—Parkinson's disease	5.7e-06	2.5e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK8—Parkinson's disease	5.68e-06	2.49e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.63e-06	2.47e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—INS—Parkinson's disease	5.59e-06	2.45e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.57e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK8—Parkinson's disease	5.5e-06	2.41e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK8—Parkinson's disease	5.5e-06	2.41e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TH—Parkinson's disease	5.49e-06	2.41e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—INS—Parkinson's disease	5.37e-06	2.35e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—Parkinson's disease	5.37e-06	2.35e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.27e-06	2.31e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—INS—Parkinson's disease	5.19e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—INS—Parkinson's disease	5.19e-06	2.28e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—Parkinson's disease	5.12e-06	2.24e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—INS—Parkinson's disease	4.87e-06	2.13e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—COMT—Parkinson's disease	4.66e-06	2.05e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.64e-06	2.04e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.63e-06	2.03e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—INS—Parkinson's disease	4.59e-06	2.01e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.58e-06	2.01e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—Parkinson's disease	4.49e-06	1.97e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.39e-06	1.93e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.27e-06	1.87e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.09e-06	1.79e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—Parkinson's disease	4e-06	1.75e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—Parkinson's disease	3.97e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—Parkinson's disease	3.87e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—Parkinson's disease	3.87e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—Parkinson's disease	3.84e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—Parkinson's disease	3.84e-06	1.69e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—Parkinson's disease	3.79e-06	1.66e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.77e-06	1.65e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK8—Parkinson's disease	3.67e-06	1.61e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—Parkinson's disease	3.63e-06	1.59e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK8—Parkinson's disease	3.55e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK8—Parkinson's disease	3.55e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—Parkinson's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—Parkinson's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—Parkinson's disease	3.51e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—Parkinson's disease	3.35e-06	1.47e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—Parkinson's disease	3.24e-06	1.42e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—Parkinson's disease	3.24e-06	1.42e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—INS—Parkinson's disease	3e-06	1.32e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—Parkinson's disease	2.35e-06	1.03e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—Parkinson's disease	2.27e-06	9.95e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—Parkinson's disease	2.27e-06	9.95e-06	CbGpPWpGaD
